Cytokine pathways in the pathogenesis of idiopathic Multicentric Castleman Disease

被引：0
|
作者：
Uhlfelder, D. [1 ]
Schaefer, H. [1 ]
Blanfeld, M. [1 ]
Andruszewski, D. [1 ]
Schelmbauer, C. [1 ]
Gaida, M. [2 ]
Waisman, A. [1 ,3 ]
Mufazalov, I [1 ,3 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Mainz, Germany
[2] Univ Med Ctr Mainz, Inst Pathol, Mainz, Germany
[3] Res Ctr Immunotherapy FZI, Mainz, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 142
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [41] Multicentric Castleman's Disease, Associated with Idiopathic Thrombocytopenic Purpura
    Sood, Ruchi
    Taylor, Harris C.
    Daw, Hamed
    CASE REPORTS IN HEMATOLOGY, 2013, 2013
  • [42] TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease
    Srkalovic, Gordan
    Marijanovic, Inga
    Srkalovic, Maya B.
    Fajgenbaum, David C.
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2017, 17 (02) : 81 - 84
  • [43] Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy
    Bayram, Ertugrul
    Pehlivan, Umur Anil
    Fajgenbaum, David C.
    Paydas, Semra
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (02) : 361 - 364
  • [44] Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome
    Sumiyoshi, Remi
    Koga, Tomohiro
    Kawakami, Atsushi
    BIOMEDICINES, 2024, 12 (06)
  • [45] Idiopathic Multicentric Castleman Disease Interactive Disease Awareness and Educational Tool for Pathologists
    Sabattini, Elena
    Neff, Jadee
    Alapat, Daisy
    Tousseyn, Thomas
    Rymkiewicz, Grzegorz
    de Paula, Henrique Moura
    Kamaradova, Katerina
    Montes Moreno, Santiago
    Lade, Stephen
    BLOOD, 2022, 140 : 13033 - 13034
  • [46] Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease
    Otoshi, Ryota
    Sekine, Akimasa
    Muraoka, Tatsuya
    Iwasawa, Tae
    Takemura, Tamiko
    Matsushita, Shoichiro
    Okudela, Koji
    Kitamura, Hideya
    Baba, Tomohisa
    Ogura, Takashi
    ADVANCES IN RESPIRATORY MEDICINE, 2023, 91 (02) : 164 - 173
  • [47] Predictive Model for Idiopathic Multicentric Castleman Disease Supporting Treatment Decisions
    Fang, Xiaosheng
    Sun, Zhongling
    Xu-Monette, Zijun Y.
    Young, Ken H.
    ONCOLOGIST, 2021, 26 (01): : 4 - 6
  • [48] Healthcare resource utilization and morbidities in patients with idiopathic Multicentric Castleman Disease
    Mukherjee, Sudipto
    Martin, Rabecka
    Sande, Brenda
    Kauffman, David
    Paige, Jeremy
    Fajgenbaum, David
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S100 - S101
  • [49] ACQUIRED HEMOPHILIA: A RARE COMPLICATION OF PEDIATRIC IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE
    Appell, Lauren
    Mack, Joana
    Stine, Kimo
    Crary, Shelley
    Farrar, Jason
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [50] CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
    Sheila K. Pierson
    Laura Katz
    Reece Williams
    Melanie Mumau
    Michael Gonzalez
    Stacy Guzman
    Ayelet Rubenstein
    Ana B. Oromendia
    Philip Beineke
    Alexander Fosså
    Frits van Rhee
    David C. Fajgenbaum
    Nature Communications, 13
12345